Multivariate logistic regression analysis: odds of complications according to platelet-testing status
| Complication | ORa | 95% CI | P Value |
|---|---|---|---|
| Primary outcome: neurologic morbidity and neurologic mortality | 2.37 | 0.95 to 5.93 | .06 |
| Secondary outcomes | |||
| Spontaneous rupture | 1.46 | 0.28 to 7.67 | .65 |
| Intracranial hemorrhage | 6.56 | 0.50 to 85.80 | .15 |
| Ischemic stroke | 2.03 | 0.67 to 6.20 | .21 |
| Parent artery stenosis | 0.06 | <0.001 to 24.51 | .37 |
| Cranial neuropathy | 1.17 | 0.22 to 6.38 | .85 |
| Neurologic mortality | 3.24 | 0.80 to 15.01 | .13 |
| Neurologic morbidity | 3.25 | 1.10 to 9.61 | .03 |
| All-cause mortality | 3.67 | 0.81 to 16.74 | .09 |
↵a Shown are the odds in the platelet testing/PED group versus those in the PED alone group. For each of the complications, the OR is for the platelet testing/PED versus the PED alone group. The analysis was adjusted for age, gender, aneurysm size, number of aneurysms treated, use of multiple PEDs, practitioner's previous experience, and center volume.